Literature DB >> 19169966

Association between genetic and environmental factors and the risk of Alzheimer's disease.

Maria Styczyńska1, Joanna B Strosznajder, Dorota Religa, Małgorzata Chodakowska-Zebrowska, Anna Pfeffer, Tomasz Gabryelewicz, Grzegorz A Czapski, Małgorzata Kobryś, Gytis Karciauskas, Maria Barcikowska.   

Abstract

The only well confirmed genetic risk factor for sporadic Alzheimer's disease (AD) is the possession of apolipoprotein E (APOE) epsilon4 allele. As it contributes to 40-70% of AD cases, a large proportion of genetic variance may be determined by additional loci. Our aim was to estimate how reported genetic factors (APOE, NOS3, MTHFR) interact to increase the risk for AD and combine them with environmental factors (homocysteine, vitamin B12, cholesterol). Genotyping was performed in 154 AD patients and 176 healthy controls. Levels of homocysteine, vitamin B12 and cholesterol were assessed in subgroups of 100 AD patients and 100 controls. We found a difference in APOE epsilon4 and NOS3 G/G distribution between groups (p<0.005). Plasma total homocysteine was increased and vitamin B12 decreased in AD patients (p<0.001). The influence of APOE epsilon4 and NOS3 G alleles on the risk of AD was independent of homocysteine, vitamin B12 levels and MTHFR status.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19169966

Source DB:  PubMed          Journal:  Folia Neuropathol        ISSN: 1509-572X            Impact factor:   2.038


  12 in total

1.  Tritium-labeled (E,E)-2,5-bis(4'-hydroxy-3'-carboxystyryl)benzene as a probe for β-amyloid fibrils.

Authors:  Sergey V Matveev; Stefan Kwiatkowski; Vitaliy M Sviripa; Robert C Fazio; David S Watt; Harry LeVine
Journal:  Bioorg Med Chem Lett       Date:  2014-10-06       Impact factor: 2.823

2.  Genetic evidence for the involvement of variants at APOE, BIN1, CR1, and PICALM loci in risk of late-onset Alzheimer's disease and evaluation for interactions with APOE genotypes.

Authors:  Jalal Gharesouran; Maryam Rezazadeh; Aziz Khorrami; Morteza Ghojazadeh; Mahnaz Talebi
Journal:  J Mol Neurosci       Date:  2014-07-15       Impact factor: 3.444

3.  Cobalamin deficiency, hyperhomocysteinemia, and dementia.

Authors:  Steven F Werder
Journal:  Neuropsychiatr Dis Treat       Date:  2010-05-06       Impact factor: 2.570

Review 4.  Methylenetetrahydrofolate Reductase (MTHFR) C677T Polymorphism and Alzheimer Disease Risk: a Meta-Analysis.

Authors:  Vandana Rai
Journal:  Mol Neurobiol       Date:  2016-01-28       Impact factor: 5.590

5.  Nitric oxide as an initiator of brain lesions during the development of Alzheimer disease.

Authors:  Gjumrakch Aliev; Hector H Palacios; Amanda E Lipsitt; Kathryn Fischbach; Bruce T Lamb; Mark E Obrenovich; Ludis Morales; Eldar Gasimov; Valentin Bragin
Journal:  Neurotox Res       Date:  2009-05-30       Impact factor: 3.911

Review 6.  Pathology supported genetic testing and treatment of cardiovascular disease in middle age for prevention of Alzheimer's disease.

Authors:  Maritha J Kotze; Susan J van Rensburg
Journal:  Metab Brain Dis       Date:  2012-04-19       Impact factor: 3.584

7.  The pathogenesis of Alzheimer's disease: a reevaluation of the "amyloid cascade hypothesis".

Authors:  R A Armstrong
Journal:  Int J Alzheimers Dis       Date:  2011-02-07

Review 8.  Potential Links between Impaired One-Carbon Metabolism Due to Polymorphisms, Inadequate B-Vitamin Status, and the Development of Alzheimer's Disease.

Authors:  Barbara Troesch; Peter Weber; M Hasan Mohajeri
Journal:  Nutrients       Date:  2016-12-10       Impact factor: 5.717

9.  Causal association of circulating cholesterol levels with dementia: a mendelian randomization meta-analysis.

Authors:  Xiaoyu Zhang; Qiuyue Tian; Di Liu; Tao Geng; Xizhu Xu; Siqi Ge; Deqiang Zheng; Lijuan Wu; Manshu Song; Haifeng Hou; Wei Wang; Youxin Wang
Journal:  Transl Psychiatry       Date:  2020-05-12       Impact factor: 6.222

10.  Biothiols and oxidative stress markers and polymorphisms of TOMM40 and APOC1 genes in Alzheimer's disease patients.

Authors:  Michal Prendecki; Jolanta Florczak-Wyspianska; Marta Kowalska; Jan Ilkowski; Teresa Grzelak; Katarzyna Bialas; Malgorzata Wiszniewska; Wojciech Kozubski; Jolanta Dorszewska
Journal:  Oncotarget       Date:  2018-10-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.